Peter Reynolds

The life and times of Peter Reynolds

Archive for the ‘food’ Category

The FSA’s Intervention in the CBD Market is a Farce. Here’s the Clear and Simple Solution.

with 2 comments

I’m not sure whether to laugh or cry about the mess the Food Standards Agency (FSA) has got itself into in the cannabidiol (CBD) market.  After imposing costs of millions of pounds on business for no good reason, its deadlines have been missed, it’s got very few products on its ‘approved’ list and the whole situation is chaos.  It’s changed the staff involved (again) and there is no sign it is going to achieve anything except fritter away more taxpayers’ money and impose more unnecessary costs on more businesses.

It was always going to be a disaster because deeming CBD products ‘novel foods’ was false from the beginning. It was the European Commission (EC) that first imposed this nonsensical ruling, refusing to consider the comprehensive evidence submitted by the European Industrial Hemp Association (EIHA) that extracts of CBD (and other cannabinoids) have been widely used in foods since as long ago as the 12th Century. Then, in anticipation of Brexit, the FSA, with no good reason, chose to adopt the EC’s novel foods policy and so this sad and futile story began.

The CBD market does need better regulation but ‘novel foods’ doesn’t address any of the issues of concern at all. It is a completely misguided policy.

There is no evidence of anyone, anywhere in the world, ever coming to any harm from consuming CBD as a food supplement, so the whole basis of deeming it as a ‘novel food’, as well as being false, is predicated on nothing. The reason for ‘novel foods’ regulation is safety and there is no evidence that CBD is unsafe.

There are just two issues which need addressing in regulating a CBD product: what the product contains and how it is marketed.

The first can be solved, at a stroke, by requiring all products to have an independent laboratory test certificate.  Not a certificate of analysis (COA) from a laboratory commissioned by the supplier but a certificate from an independent laboratory that has itself been certified by the regulator which, yes, should be the FSA. So this independent, ‘official’ COA will specify the cannabinoid content, certify that controlled cannabinoids are within the legal limit and that heavy metals and other contaminants are within prescribed safety limits.

The second can be solved, at a stroke, by properly funding the Medicines and Healthcare products Regulatory Agency (MHRA) to fulfil its function as regulator of the Human Medicines Regulations 2012, the law that prohibits claims of medical benefit being made for commercial gain about products which are not licensed as medicines.  The MHRA has dismally failed to fulfil this function, which is ironic as it first brought CBD to regulatory attention in 2016 over the issue of these medical claims.  It simply does not have the resources to do this job. Hundreds of reports have been submitted to the MHRA by the two trade associations, the CTA and CannaPro, but not acted upon.  As a result the law is now widely ignored both by unethical suppliers and by all the national newspapers which regularly run unlawful advertisements and advertorials despite the fact that in theory, the maximum penalty for these offences is two years in jail.

These two steps, taken together, will completely solve the regulatory requirements for the CBD market.

 

Courage and Cannabidiol

with 2 comments

The story of how brave British small-businesses created a £1.7 billion market and now face destruction at the hands of the overbearing Food Standards Agency and its big business sponsors.

Hundreds of people who set up small businesses selling CBD products face the looming deadline of 31st March 2021 that the Food Standards Agency (FSA) has imposed for its ‘novel foods’ regulations to come into force.

These people, the essence of the British entrepreneurial spirit, are being crushed by misguided over-regulation that is not based on any evidence and which will gift the market to big business while removing from shelves the products which millions of people have gained great benefit from.

The FSA has not consulted with the industry in any meaningful fashion and is imposing draconian new rules which even at this late stage remain unclear, confusing and require enormous, unnecessary and wasteful expenditure in pointless bureaucracy.

To be clear, if you are one of those millions who discovered that CBD could help with anxiety, pain, insomnia and or a host of other conditions, the products you rely on may not be available much longer.  But there is a way through this. Read to the end of this article to find how you will still be able to access the ‘real CBD’ that you need.

The most important thing to understand is that there is no evidence anywhere in the world that anyone has ever come to any real harm from using CBD products. Despite this, the FSA is forcing businesses to put their products through an incredibly complex series of tests which cost a huge amount of money, in some instances hundreds of thousands of pounds.

Even the smallest companies are having to submit a dossiers on individual products which cost around £5000 each to produce.  Imagine how many bottles of CBD oil a small shop or website has to sell to pay for just one of these.  And they are completely pointless.  There is no need for them at all.  The FSA has just invented them and it’s nothing to do with public safety because there is no danger from any of the products concerned.

The Association for the Cannabinoid Industry

What this is really about is that big business missed out on the CBD boom.  They turned their corporate noses up at it, didn’t want to get involved because of the stigma and prejudice associated with anything to do with cannabis.  Then, within the space of a few years, they found that all their big customers, the multiples, were starting to stock CBD and it was selling very well indeed.  So much so that the value of CBD sold in Britain is now more than the value of all vitamin C and vitamin D products combined. It’s a huge market with estimates of its size ranging from £300 million to £1.7 billion per year (New Frontier Data).

So big business is now calling the shots.  A sinister organisation, the Association for the Cannabinoid Industry (ACI), run by a man, Steve Moore, with connections to the sleaziest end of the Conservative Party, is supporting the FSA in this scheme and his aim is simply to price small businesses out of the market and hijack it for his big business friends. Never has a bigger confidence trick been pulled on consumers. The small businesses that created the CBD market had established trade associations from within their own ranks which charged a few hundred pounds for membership and did an excellent job of representing the industry. The ACI demands membership fees of £25,000 per year, pricing out the small businesses and using its funding to bully and intimidate any business that doesn’t want to sign up.

Steve Moore of the Association for the Cannabinoid Industry

There are problems in the CBD market that need addressing. It does need better regulation. There are disreputable businesses selling products that are not what they claim.  They don’t have the amount of CBD in them that is advertised and they are certainly not medicines which can treat cancer, diabetes, depression and serious illnesses.  But these problems are already covered by existing laws. The problem is they are simply not being enforced.  The regulators who should be acting against these rogue companies include the Medicines and Healthcare products Regulatory Agency (MHRA), the Advertising Standards Authority (ASA) and Trading Standards.  Despite reputable CBD businesses delivering hundreds of reports about rogue suppliers, virtually nothing has been done.  To be fair the MHRA and Trading Standards just don’t have the resources to carry out this work, so the idea of giving them even more work, with incredibly complex regulations to enforce, is just barmy.  It makes no sense.

The Human Medicines Regulations 2012

Even our largest newspaper publishers have been allowed to get away with breaching the Human Medicines Regulations 2012 which prevent anyone from making a commercial gain out of claiming medicinal benefit for a product which is not a licensed medicine. This criminal offence can result in a two year prison sentence, yet the Daily Mail runs such ads every day.  So do most of the tabloids and those newspapers that like to call themseleves ‘quality’, do something equally illegal. They run advertorials or sponsored reviews of products which if you click and buy pay the publishers commission.

These crimes have been reported to the MHRA and to the ASA but they have done nothing about it and the illegal advertising continues to this day.  As for the confidence trickster companies making these illegal medicinal claims, nothing has been done about them either and they continue to scam people with cancer cures and miracle medicines.  Now the ACI is using this conduct as part of the justification for their ‘novel foods’ scam. Of course the two issues are completely unrelated.

But all is not lost.  Undoubtedly, the ‘real CBD’, the whole plant extract, containing all the goodness and nourishment extracted from low-THC cannabis plants, will be taken off the shelves of the multiples but there will be a flourishing ‘grey’ market, mainly online and there will be nothing that the FSA, ACI or their enforcers will be able to do about it.

The FSA’s understanding of CBD and cannabis is virtually non-existent. The original CBD trade associations spent years trying to educate FSA’s people and urging them to co-operate on appropriate regulation but they didn’t want to know. Now the FSA has chosen to listen to its own and ACI’s ‘experts’ who are trained and indoctrinated in the prohibition mindset. Consequently its statements and rulings on its new regulations are so poorly drafted that they leave a gaping hole for the brave, pioneering businesses that created this market.  A genuine, whole plant oil that preserves the natural proportions of the compounds in the hemp plants from which it is extracted is molecularly identical to those plants and hemp is specifically excluded from novel foods regulations.

So ‘whole plant’ is what you must look for if you want ‘real CBD’, the product that so many people benefit from.  The ACI and FSA are pushing nasty, ineffective isolates and synthetics that are useless in comparison and require far higher doses to achieve the same results as a few drops of whole plant oil.

One More Problem as the Home Office Steps In on THC Levels

CBD originally took off because more and more people were becoming aware of the medicinal benefits of cannabis. CBD was seen as a way to enjoy some of these benefits legally and without getting ‘high’ from the THC in cannabis.  But CBD was always a euphemism to avoid the stigma around cannabis and to reassure people they weren’t buying something illegal. In fact, whole plant CBD products are low-THC cannabis oil.  Under a provision of the Misuse of Drugs Regulations, a trace amount of 1mg of THC per bottle of CBD oil has  been allowed. It’s far too little to get anyone high. You’d have to drink about three bottles in one go before you felt anything.

But surprise, surprise, now the Home Office has started to get involved too. Again, without a shred of evidence of any harm, it is considering reducing this limit very substantially.

Why?

Undoubtedly this is co-ordinated with the FSA and the ACI. The aim is the same, to destroy the small businesses that created this market, to ramp up the costs of selling CBD so high that only big business can afford it and to prohibit the sale of the whole plant, low-THC cannabis oil that is so valuable for so many people.  And there is no credible evidence to support any of it, except what the FSA has cooked up to support its pre-determined conclusion. There is no evidence that the trace amounts of THC in whole plant oil have or could cause anyone any harm and it is all part of the same scam.

So remember, if you want ‘real CBD’, you’re going to have to go online. Look for those courageous businesses that provide whole plant extracts and avoid isolate or synthetic products which are a waste of money.

Review. CannaErbs, CBD Infused Herbs and Spices

leave a comment »

There is a very wide range of products now available that have added or infused CBD.  I finally decided this had become a little crazy when the CBD infused gym leotard came out.  But food with CBD in it is a natural fit. The thing is, I have no taste for sickly chocolate brownies or Krispy Kreme doughnuts which I think should definitely be a Class A drug.  So I was very pleased to hear about this range of CBD infused herbs and spices.

First things first, this is ‘real CBD’, not that nasty, useless isolate or synthetic that the Food Standards Agency and big business are trying to force on us.  These seasonings are hand blended with broad spectrum, THC-free cannabis extract.  I’ve been experimenting with them over the last few weeks and they are delicious, a very welcome addition to my food cupboard.

The vaporisation point of CBD is between 160 degrees and 180 degrees Celsius. That being said, CBD can be baked or cooked and still retain most of its nutritional benefits.  If you’re baking the internal temperature in the food is going to be significantly less than the oven but you do need to be careful with frying.  In this case you’re best off adding any CBD at the end of cooking.

I stumbled across a particularly tasty use for the Piri Piri flavour.  It works wonders in bubble and squeak!

Each jar of CannaErbs contains 50mg CBD, costs £3.99 in a grinder or £2.99 as a refill and they are are available in the following flavours:

All Purpose
Barbeque
Chilli
Creole
Jerk
Mixed Herbs
Piri Piri
Salt n Pepper
Seafood

Use this discount code PETER20 to get 20% off at https://cannaerbs.co.uk/

 

Written by Peter Reynolds

February 28, 2021 at 7:43 pm

Posted in food, Product Review

Tagged with , ,

An Update On CBD, the Novel Food Scam and the Fatcats Who Plan to Take Over the Market.

with 3 comments

The CBD Market Has Been Built By Small British Businesses.

It is About To Be Stolen By Government-Backed Big Business.

Over about the last five years, small British businesses have built the CBD market from zero to hundreds of millions in annual sales. It’s been driven by rapidly changing attitudes towards cannabis and a realisation that many of its medicinal benefits could be available legally by using traditional hemp extracts.

Big business, the established supplement and health food companies weren’t interested. They saw the stigma around cannabis before they saw the changing attitudes.

Now it’s all very different. Millions of people are using CBD. All the big multiples are stocking it. It’s become a media fascination and many people say they gain great benefit from it. Suddenly, big business and all the regulators are interested. Suddenly those who weren’t bothered previously are cautioning about all sorts of dangers and concerns. They don’t actually have any evidence of CBD products causing any harm but clearly they don’t think these small, independent businesses can be trusted anymore. Of course, the truth is they want a slice of the action – or preferably all of the action if they can get their chums in government and the bureaucracy to step in and assist with their plans.

In fact the British CBD industry has been a model of responsible self-regulation. Two trade associations, the CTA and CannaPro, represent virtually all the leading UK suppliers and maintain high levels of quality control and trading standards, including regular reporting of non-compliant businesses to the MHRA.

But in June this year, the Centre for Medicinal Cannabis (CMC) published a sensational report alleging that most of the CBD on the market was very poor quality, contained illegal levels of THC and some contained no CBD at all.

Its report was presented as some sort of independent, academic study that should be regarded as science. It wasn’t. It was a cheap marketing stunt. Sure enough, just a few  weeks later it announced that all its members’ products were good quality and there was no problem with them.

Now the CMC has thrown itself in with the EU and is backing the classification of CBD products as ‘novel foods’, meaning that any business selling CBD would have to apply for an authorisation at a cost of at least £250,000 in a process taking perhaps two years to complete.  The CMC has also aligned itself with an interpretation of the law on THC levels in CBD products which is completely at odds with the established industry.  It has sided with the Home Office that there cannot be any THC at all, whereas the industry relies on a  definition of ‘exempt products’ in the Misuse of Drugs Regulations 2001 which permits up to 1mg of THC in each container.

As Brexit approaches, the Food Standards Agency (FSA) is expected to issue guidance on enforcement of the novel foods classification.  If it acts before Brexit then the position will be carried over in the Withdrawal Agreement.  And now the CMC has launched yet another trade body, the Association for the Cannabinoid Industry, (ACI) which it is implying will enable CBD suppliers to enjoy a ‘grace period’ from FSA enforcement.

It would be unlawful for the FSA to make any arrangements or offer any ‘grace period’ to CMC or ACI members that is not available to any other business. Mike Harlington of the CTA tried this on before, claiming he had made special arrangements with the FSA for CTA members only. None of this is true. These claims are confidence tricks but the CMC/ACI is pushing it with the requirement to sign up to membership at a cost said to be between £10,000 and £50,000 per year, completely prohibitive for the small businesses that have worked so hard to develop this industry.

The Centre For Medicinal Cannabis Is A Wolf In Sheep’s Clothing,

The ‘Big Pharma’ Of British Medicinal Cannabis And CBD.

The CMC appeared sometime in 2018 announcing itself as the UK’s first and only industry membership body for businesses and investors operating in cannabis based medicinal products (CBMPs) and cannabidiol (CBD) wellness markets.  This, of course, is nonsense. It’s about the fifth or sixth to set itself up as a trade body in this market and it’s certainly not the only.  Between them, the CTA and CannaPro represent hundreds of businesses with millions of satisfied customers.  The CMC has only a handful of members.

What the CMC/ACI does have is a great deal of money from its backer, the multimillionaire Paul Birch and a great deal of influence from ex-David Cameron ‘fixer’, Steve Moore, who knows all the right people in all the establishment elites and knows how to pull their strings.  In just a few short months it has pumped a fortune into PR and media relations and made itself the go to source for anything on medicinal cannabis and CBD.  It has also bought and paid for a large number of highly qualified people with impressive credentials who inevitably carry great weight with the authorities. Its ambitions are clear.  It intends to destroy the small businesses that built this market and seize it all for itself and it looks as though it may well succeed.

CannaPro spoke with the FSA earlier this week.  For the moment, the FSA cannot act as we are in election ‘purdah’, the civil service can’t really do anything except keep the status quo but that will all change after the election.  Then, depending on the new government, it may move rapidly to commence enforcement. What this will mean is impossible to predict but almost certainly the multiples will take stock off the shelves unless some interim arrangements are agreed.  Those with retail premises will be in the most immediate danger, online sellers will be in a better position but if Trading Standards officers try to seize stock, they have extraordinary powers and trying to obstruct them may result in arrest.

Of course, the novel foods classification is fake and a lot of evidence has been presented to prove this but it is simply being dismissed. It’s rather like the way the medical establishment dismisses the evidence on medicinal cannabis.  If these institutions don’t like evidence they simply ignore it.  For obvious reasons, it suits the CMC to get behind the novel food scam but the result for consumers will be a lot less choice and probably substantial price rises. It’s also very bad news for CBD businesses.  A lot of people are likely to lose their jobs.

 

Written by Peter Reynolds

October 31, 2019 at 9:35 pm

Mischievous ‘Centre for Medicinal Cannabis’ Report Smears UK CBD Industry With Misleading Data

leave a comment »

A new report from the Centre for Medicinal Cannabis (CMC) paints an appalling picture of the CBD market in the UK and has led to headlines and alarm everywhere that consumers are being ripped off and the whole industry is not to be trusted.

Cannabis has great medical potential. But don’t fall for the CBD scam – The Guardian

Calling on the UK CBD sector to have better regulation and reform – Health Europa

Centre for Medicinal Cannabis survey finds six million adults used CBD in UK – NHS Executive

CBD oil brands contain little to no CBD, test by Sativa’s UK lab reveals – Proactive Investors

It is true that there are some rogue businesses and fake products but the impression given by this report is false, misleading and wildly inaccurate.  For nearly three years the leading CBD businesses in the UK have been engaged in serious, responsible self-regulation and consumers can be confident if they buy from members of the two trade associations Cannabis Professionals (CannaPro) or Cannabis Trades Association (CTA) they will be getting a quality product which is lab tested and contains exactly what is claimed.

The report is nothing but a market manipulation exercise by the authors. To understand why, it’s necessary to understand who is behind the ‘Centre for Medicinal Cannabis’ and examine their record.

The CMC is the latest front for Paul Birch, a multimillionaire, who since 2015 has been funding a series of ventures in the cannabis campaign. Mr Birch has brought one extremely valuable commodity to the campaign which it had been sorely lacking – money.  He has hired a lot of people with the right connections, impressive letters after their name and has thrown a great deal of his cash into expensive PR which, to be fair, has proved very effective. In fact, as with this CBD report, it is characterised by just how much media coverage it has obtained.  This, of course, has earned Birch’s cannabis ventures a reputation as leaders in their field. In fact, they are very much followers.  The content of their work is either directly copied from others’ work or is just a repeat of what has been done before.

The most high profile success achieved with Birch’s money and PR was the campaign around Billy Caldwell and Alfie Dingley, two children with severe epilepsy, whose stories touched the heart of the nation and under enormous moral pressure forced the UK government into long-overdue reform of its blanket ban on cannabis as medicine.  Birch’s money certainly made all the difference. Exactly the same stories and messages had been delivered to the media many times before but it is a fact of life that you only get on to the breakfast and daytime TV shows and in all the tabloids with a very expensive PR operation.

So Birch is at it again with the CMC. It describes itself as the UK’s first and only industry membership body for businesses and investors operating in cannabis based medicinal products (CBMPs) and cannabidiol (CBD) wellness markets.“, which is as wholly false a claim as has ever been published about anything, anywhere.

The existing trade associations, CannaPro and the CTA, were formed years before the CMC and between them represent nearly 1,000 businesses operating in the legal cannabis sector.  Neither of them were consulted before or since the CMC’s report and the fact of their existence and the work they do in regulating the industry has been excluded from the report.

Of course, the CMC won’t name the products which its report showed to be so deficient because this would show that they are not from members of CannaPro or CTA and are therefore not at all representative of what consumers are actually buying. The irony is that PhytoVista, the lab used by the CMC, is itself a member of the CTA and provides testing services to many CannaPro and CTA members.

So take the results of the CMC CBD report with a very large pinch of salt, or perhaps with a tablespoon of hempseed oil containing only a trace of CBD.  It doesn’t tell the truth. It paints a false picture of an industry that is actually a model of self-regulation.

Written by Peter Reynolds

July 9, 2019 at 3:38 pm

Review. Gincanna Hemp-Infused Gin

leave a comment »

Adding CBD oil to drinks has become de rigeur in the past year or two. Even Coca Cola has expressed interest in entering the market. So when I first heard of CBD-infused alcoholic drinks I was intrigued. Gincanna is a result of a joint venture between CBD company Ev8 Life and Selkirk Distillers and it certainly offers a new twist on your usual G&T.

It’s not about the therapeutic or ‘wellness’ properties of CBD, it’s about flavour, so gin is the obvious candidate for such an idea because it is essentially a neutral tasting spirit infused with juniper berries and other botanicals which give each product its individual flavour.

To those who find the taste of CBD oil quite disgusting this may seem strange! Please take it from me that cannabis can provide a very pleasant flavour ingredient if used properly.  The classic hash brownie is perhaps the best example. A good recipe delivers a delicious earthy, herbal richness which blends very well with moist chocolate cake. Gincanna successfuly achieves the same sort of alchemy and although it’s a completely different context, it’s equally delightful.

Taking my tasting responsibilities very seriously, I sampled Gincanna neat to begin with, not something I would usually do with gin.  The earthy taste is not very prominent but remarkably when you add tonic and lemon that seems to bring it out.

It’s a successful blend, more than just a talking point and with the boom in trendy gin brands this is something that could do very well. Gordons, Bombay Sapphire or Gincanna, the choice is yours and it will be good to see it offered in all the most fashionable bars and at the most sophisticated occasions.  I can personally verify that a Ginacanna and tonic goes down very well on a summer’s evening with a nice, fat joint!

Written by Peter Reynolds

June 12, 2019 at 4:08 pm

Posted in food, Product Review

Tagged with , , , ,

The CBD Market Can Help Drive Cannabis Law Reform But Selling So-Called ‘CBD Flowers’ Could Take Us Backwards

leave a comment »

Jim Weathers of Puff ‘n Stuff CBD shop, Cork, Ireland

Compliant businesses operating responsibly within the legal cannabis sector will help to drive reform. Blurring the lines between legal and illegal products will delay progress.

It seems that the crackdown on the open sale of cannabis flowers online and in high street stores is here.  Both in the UK and Ireland, several shops have been raided in recent weeks and some people are facing potential charges of supplying a class B drug and a possible jail sentence.

These flowers, sold under meaningless pseudonyms such as ‘CBD buds’ or ‘hemp flowers’ are cannabis and cannabis is a controlled drug in both the UK and Ireland.  As CLEAR has been warning for many months, there is no way that these can ever be ‘exempt products’ in the same way as CBD oil.  Their THC content makes no difference. The penalty is the same for any type of cannabis whether it contains zero THC or 25% THC.

It’s unclear whether CBD oil is legal at all in Ireland.  A more accurate description for these products is low-THC cannabis extracts and whereas the UK makes specific provision for exempt products in the Misuse of Drugs Regulations 2001, there does not seem to be any such provision in Irish law.

In other EU countries an even wider crackdown on CBD products is underway, fuelled also by the extraordinary and clearly unsustainable attempt to deem all cannabis extracts as ‘novel foods’.

Now it shouldn’t need to be said but CLEAR stands for an end to the prohibition of cannabis and all our work is directed towards that end.  Some people seem very confused that our efforts to clarify the law mean that we are on the side of prohibition but this is not the case.  Through our trade association, Cannabis Professionals (CannaPro) we refuse to certify businesses that sell cannabis flowers.  They are cheating their customers by misleading them that these products are legal.  They are also cheating all those other businesses operating within the legal cannabis sector who are working hard to remain compliant.  They are undermining the very good work that the CBD industry is doing to drive wider cannabis law reform.

Of course, many of us are buying cannabis illegally already.  Without our local dealers where would we all be under the oppressive and ridiculous regime under which we live? But our aim and the aim of all responsible cannabis campaigns is to ‘get the dealers off the street’ and move the trade into licensed, regulated outlets.  The emergence of the CBD market and high street retailers selling CBD oil has shown how this could work and there is no doubt at all that it has been a very significant factor in increasing public acceptance of cannabis and the recent reforms for medical access.

The people selling cannabis flowers and claiming they are legal are not heroes, campaigners or warriors in the war on prohibition. They are confidence tricksters, seizing the opportunity to make a quick buck by cheating and endangering their customers. No one is going to go to jail for buying cannabis but if you’ve bought low THC flowers and get charged with possession that could ruin you future prospects of travel, a career, even of keeping your driving licence.  If you’re going to take that risk you need to do so with your eyes open, with the honest trade of an illegal dealer rather than the dishonest trade of a shop or a website that is telling you lies.

Also, be very careful what you are buying.  The ‘CBD flowers’ currently being advertised are most certainly not what they claim to be.  The strain names are being misused.  White Widow, Lemon Haze or Pineapple Express do not come with 20% CBD and only traces of THC.  These products have been doctored.  There simply aren’t any cannabis strains that contain these constituents in these proportions.  What is probably happening is that they are being sprayed with CBD isolate and possibly terpene extracts to come with what are artificial cannabis buds.  Buy these and you are being cheated on many levels and you really don’t know what you are actually inhaling.

We are making steady and accelerating progress towards a rational cannabis policy but this latest development is unwelcome and unhelpful.  Trust your usual dealer.  If you’re buying cannabis flower, it comes with THC.  If you want added CBD take a little oil or vape some CBD crumble.  This will give you a far better result than these fake flowers. It will enhance the therapeutic properties of your cannabis if you’re consuming for medical reasons.  It will give you a far better buzz if you’re consuming for pleasure.

Nothing good will come from these fake flowers. Compliant businesses operating responsibly within the legal cannabis sector will help to drive reform. Blurring the lines between legal and illegal products will delay progress.

 

 

Written by Peter Reynolds

May 21, 2019 at 2:40 pm

The EU’s Attempt To Deem Cannabis Extracts As Novel Foods Will Fail.

with one comment

Status of Hemp Extracts in Europe – European Industrial Hemp Association

The European Industrial Hemp Association (EIHA) has published an excellent eight page document which refutes the recent move by EU food safety agencies to deem cannabis extracts as ‘novel foods’.

Download the document here.

The document explains the entire situation and demonstrates very clearly that this move by the EU is misguided. It shows how these products have been consumed in Europe fro many years, if not centuries, probably millennia and that the EU has previously confirmed in writing that they are not novel.

Aside from these fundamental issues, there are a number of reasons why the process the EU and the UK Food Standards Agency (FSA) have followed is flawed and unlawful.

What seems absolutely clear is that this initiative, which is intended to close down the burgeoning CBD market, is based on the intervention of vested interests which are concerned to see a multimillion pound/euro industry emerge in the space of a few years, almost exclusively amongst small and medium-sized businesses.  This is an opportunity which multinational conglomerates have missed and there is no doubt that its success is affecting many existing markets, notably over-the-counter pain medicines.

The EU and government agencies such as the FSA have always been the friends of big business and the intention here has been to force small business into huge costs associated with novel food authorisation which would effectively close their businesses down.

There are many overblown conspiracy theories, particularly around cannabis for medical use and the pharmaceutical industry but this attack on the CBD market, for no valid reason, is difficult to explain in any other way. It seems certain that improper pressure has been brought to bear on these regulators and they are trying to use their powers, improperly and unlawfully, to protect the interests of big business.

They are too late.  The CBD business has grown very quickly and is now too far advanced to be closed down and there is no justifiable reason to do so.  This attempt to impose novel foods status will fail.

 

Written by Peter Reynolds

May 13, 2019 at 10:20 am

CBD Switzerland. Whole Plant Extract From Swiss-Grown Industrial Hemp.

leave a comment »

Although something in my value system, no doubt instilled in my now very distant childhood, tells me that medicine is supposed to taste bad, there is no strict correlation between nasty taste and powerful effect.  Some cannabis extracts taste foul, others are bearable and there a few that capture the distinctive, earthy taste of the plant and are really very nice.

The first time I saw a bottle of CBD Switzerland oil, I was pretty sceptical.  It’s virtually crystal clear and I thought this is isolate in a carrier oil or it’s had all the goodness refined out of it – but the taste is just wonderful. The new trend for cooking with cannabis is a strange mix of hype, ignorance, fad-of-the-moment veganism and in a few cases its about getting high but there is a cannabis taste that is really desirable and works well in both sweet and savoury dishes.  CBD Switzerland has captured that taste in a bottle.

The lab tests and a week of regular use confirmed for me that this is very much the real thing.  There are other oils that I also rate very highly for taste but the combination of taste and clarity is stunning and I expect it is what more and more consumers will be looking for as the CBD market matures.  This is probably the most modern, consumer friendly oil on the market. No doubt, a little further down the line, the same expertise in extraction and refinement can be applied to a THC product and that will be a winner.

CBD Switzerland offers its oil in virtually any specification required, either zero THC or with the trace levels that are present in a full spectrum extract from plants with 0.2% THC.  Standard concentrations are 5%, 10%, 15%, 20% or 25% in either hempseed or MCT carrier oil.  Full spectrum soft gels are available containing 10mg CBD each.  Recently a THC-free distillate has been added with either 95% or 75% CBD content, a full spectrum, liposomal, water soluble mix and CBD vape liquid.  As a white label supplier, CBD Switzerland offers everything that a CBD business could need to formulate and produce its own products.

Download the CBD Switzerland brochure here.

Written by Peter Reynolds

April 25, 2019 at 3:42 pm

CannaPro Seizes the Initiative in the CBD and Novel Foods Debacle

with 2 comments

Cannabis Professionals (CannaPro), the trade association for the UK’s cannabis, CBD and hemp businesses, has instructed solicitors to take decisive action in the ongoing row between the Food Standards Agency (FSA) and the UK’s fastest-growing food supplement market for cannabidiol (CBD) products.

TLT Solicitors, acting on behalf of CannaPro, has sent a formal letter to the FSA warning it of the consequences of taking any enforcement action against CannaPro Certified Businesses.  An industry-wide claim for such compensation could amount to many hundreds of millions of pounds/euros.  A copy of the letter can be seen here. This offers some degree of protection to all businesses that are CannaPro Certified.

Acting in conjunction with its opposite numbers in several EU states, the FSA has sought to classify CBD products and all cannabis extracts as ‘novel’ by listing them in the EU Novel Food catalogue. This threatens to destroy a market that is now worth up to £100 million pa, employs hundreds of people and is meeting the healthcare and wellness needs of hundreds of thousands of UK citizens.

A ‘novel food’ is defined as a food or food ingredient that was not in widespread consumption in the EU area before 1997.  In reality, cannabis, in varieties known as hemp, has been consumed as food for at least 10,000 years and is listed in the Guinness Book of Records as the world’s oldest cultivated crop. The FSA’s action is irrational, defies history and reverses previous statements by the FSA that cannabis and hemp are not ‘novel’.

Peter Reynolds, president of CannaPro, said:

“The FSA has made a series of errors in the way it has handled this.  The whole process has been misguided and unlawful, not to say that the whole idea CBD products can be regarded as novel is nonsense. It has undertaken no proper consultation and although there have been vague discussions around the issue for a couple of years, the FSA has changed its position time and time again.  What’s really going on here is that big business and powerful vested interests have been caught on the hop while enterprising small businesses have established a market which is now worth an awful lot of money. Improper pressure has been brought on the regulator to find a way of clamping down.  It would suit these vested interests to see the market so strictly regulated that small businesses are unable to compete.  CannaPro is not going to stand by and let that happen.”

Written by Peter Reynolds

March 26, 2019 at 6:00 pm